About:
Due to the rapid developments in the field of medical biotechnology, the transactions that are connected with the body have developed into the most important areas of the market economy in the last few decades. This has lead to massive changes in political, economic and social structures, but also to new power relations between the institutions and social classes involved. With the methods of autotheory and artistic research my book ID9606/2a-c [Dispositive eines Virus] addresses the question of how biotechnological inventions, as areas of capitalist investment, can affect political decisions in health care. The reference point of my investigation is the rationing of the new Hepatitis C drugs in Switzerland. I am assuming a personal experience. My infection with the hepatitis C virus. For a long time, the infection was considered impossible to treat or only treatable to a very limited extent. This fact only changed when Pharmasset Inc. developed PSI-7977, which was brought to market by Gilead Siences a few years later. The possibility of an almost one hundred percent chance of recovery has been celebrated as a historic event in science and medicine. But while Gilead was able to run an unrivalled business with the new hepatitis C drugs for a long time, the "miracle of healing" remained out of reach for most of those affected. The therapies were simply too expensive and were immediately rationed by the Swiss Federal Office of Public Health. For examining the given situation, I chose an interplay of various text genres (dialogue, advertising, diary / hypomnemata, scientific text, essay and documentation) that not only encircles the subject from multiple perspectives but also crosses various disciplines in terms of content. By bringing together different forms of knowledge and genres, readers are offered different readings on the same subject.